SCHEDULE 13G/AAccepted Aug 6, 8:47 PM ET
Aspire Biopharma Holdings, Inc. SCHEDULE 13G/A
Accepted (ET)
8:47 PM
Aug 6, 2026
Filed
Aug 6, 2026
Documents
1
Size
6.7 KB
Summary
Summary not available
This filing does not have a written summary yet. You can still open the original filing and its exhibits.